Camera
Vulputate at nullam elementum iaculis metus turpis auctor molestie justo phasellus vulputate nam massa congue primis est in suscipit non convallis suscipit fusce eleifend porta egestas donec libero ultricies dictumst odio ipsum curabitur donec mollis habitasse aliquam mollis cubilia pretium fusce orci id fusce diam lobortis bibendum ut molestie pharetra.
Retatrutide is a novel triple-receptor agonist peptide currently being studied for its effects on metabolic function, body composition, and energy regulation. Unlike traditional single-target compounds, Retatrutide is designed to activate GLP-1, GIP, and glucagon receptors, making it a unique area of interest in obesity and metabolic research.
Researchers are investigating Retatrutide for its potential to:
Support reductions in body weight and body fat
Influence appetite regulation and satiety signaling
Enhance energy expenditure and metabolic activity
Improve glucose metabolism and insulin sensitivity
Support favorable changes in body composition
Investigate effects on liver fat and metabolic health
Due to its multi-receptor mechanism, Retatrutide has become a significant focus in research exploring weight management, energy balance, and metabolic optimization.
Research Use Only. Not for human consumption. This product is intended exclusively for laboratory and scientific research purposes.
| Weight | 1 lbs |
|---|---|
| Dimensions | 4 × 6 × 2 in |
| SIZE VIAL | 5MG, 10MG, 20MG, 30MG, 60MG |








Reviews
There are no reviews yet.